期刊文献+

氧化低密度脂蛋白促进培养的人肾小球系膜细胞LOX-1表达 被引量:2

In vitro Study of LOX-1 Expression on Human Mesangial Cell Induced by Oxidized LDL
原文传递
导出
摘要 目的:研究氧化低密度脂蛋白(Ox-LDL)对人肾小球系膜细胞植物血凝素样受体(lectin-like oxidized low-density lipoprotein receptor,LOX-1)表达。方法:不同浓度的Ox-LDL和培养的人肾小球系膜细胞共孵育,应用Real-time PCR和Western Blot方法检测Ox-LDL对人肾小球系膜细胞LOX-1表达的影响。结果:Ox-LDL剂量和时间依赖性促进人肾小球系膜细胞LOX-1mRNA和蛋白表达。Ox-LDL 40μg/mL刺激细胞0-24小时,于12小时达峰值。Ox-LDL 10、20、40、60μg/mL分别作用于细胞12小时,40μg/mL组达到峰值,为基础值的3.73倍。Ox-LDL 40μg/mL刺激细胞0-24小时,LOX-1蛋白24小时达高峰,Ox-LDL 10、20、40、60μg/mL分别作用细胞24小时,40μg/mL组细胞LOX-1蛋白达到峰值,为基础值的1.81倍。结论:Ox-LDL在一定浓度范围内剂量和时间依赖性促进人肾小球系膜细胞LOX-1表达。 Objective: To observe whether the expression of lectin-like oxidized LDL receptor can be induced by Ox-LDL on human mesangial cell(HMC). Methods: When cultured HMC stimulated by different doses of Ox-LDL, the levels of LOX-1 on HMC induced by Ox-LDL were examined using Real-time PCR and Western Blot. Results: Ox-LDL could induce LOX-1 mRNA and protein expression in a dose-dependent manner(10-40 μg/m L). The peak level of LOX-1 mRNA reached after 12 h of stimulation and was as high as 3.73-fold as control. The up-regulation effect on LOX-1 protein reached peak after 24 h and was as high as 1.81-fold as control treated with 40 μg/ml of Ox-LDL. Conclusions: Ox-LDL can induce LOX-1 expression in a dose and time dependent manner.
出处 《现代生物医学进展》 CAS 2015年第23期4435-4439,共5页 Progress in Modern Biomedicine
基金 北京市科委资助项目(SCW2009-07)
关键词 氧化低密度脂蛋白 人肾小球系膜细胞 植物血凝素样氧化低密度脂蛋白受体 Ox-LDL Human mesangial cell Lectin like Ox-LDL receptor 1
  • 相关文献

参考文献4

二级参考文献50

  • 1CHEN Xiu-ping DU Guan-hua.Lectin-like oxidized low-density lipoprotein receptor-1:protein,ligands,expression and pathophvsiological significance[J].Chinese Medical Journal,2007(5):421-426. 被引量:34
  • 2Chen J,Mehta JL.Role of oxidative stress in coronary heart disease.Indian Heart J 2004; 56:163-173.
  • 3Ranganathan S,Joseph J,Mehta JL.Aspirin inhibits human coronary artery endothelial cell proliferation by upregulation of p53.Biochem Biophys Res Commun 2003; 301:143-146.
  • 4Mehta JL.Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.Clin Cardiol 1998; 21:879-884.
  • 5Mehta JL,Chen J,Yu F,Li DY.Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-l in human coronary endothelial cells.Cardiovasc Res 2004; 64:243-249.
  • 6Costanzo A,Moretti F,Burgio VL,Bravi C,Guido F,Levrero M,et al.Endothelial activation by angiotensin Ⅱ through NF kappaB and p38 pathways:Involvement of NF kappaB-inducible kinase (NIK),free oxygen radicals,and selective inhibition by aspirin.J Cell Physiol 2003; 195:402-410.
  • 7Yuan M,Konstantopoulos N,Lee J,Hansen L,Li ZW,Karin M,et al.Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.Science 2001; 293:1673-1677.
  • 8Bocan TM.Pleiotropic effects of HMG-CoA reductase inhibitors.Curr Opin Invest Drugs 2002; 3:1312-1317.
  • 9Mason RP,Walter MF,Day CA,Jacob RF.Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.Am J Cardiol 2005; 96:11-23.
  • 10Li D,Chen H,Romeo F,Sawamura T,Mehta JL.Statins modulate oxidized iow-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells:role of LOX-1.J Phannacol Exp Ther 2002; 302:601-605.

共引文献33

同被引文献13

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部